BsUFA III Expands Biosimilar Supplement Review Goals To Speed Approvals
Executive Summary
Six supplement categories based on submission content will be created with review goals between three and 10 months.
You may also be interested in...
CDER, CBER Post FY 2023 Employee Gains, But Behind User Fee Hiring Goals
US FDA’s drug center reported a net increase of more than 300 employees in FY 2023, while the biologics center saw an overall increase of more than 30.
US FDA Hiring Data: CBER Exceeds CDER In Progress Toward Goals
Through three-quarters of fiscal year 2023, CBER had hired nearly 70% of the mandated new PDUFA VII employees, while CDER had only hired 40%. The drug center also hired only 36% of the required new BsUFA III employees.
US FDA’s Marks Worries Someone May Stop Hybrid Work System
CBER Director Peter Marks said the FDA’s remote and in-person work system is functioning well and continues to help recruitment.